Doseology Sciences Inc. announced appointment of Christopher P. Cherry as CFO of the Company. Bringing over 15 years of corporate accounting and audit experience, Mr. Cherry's expertise will ensure the company's financial stability and growth. His previous roles include Director, CFO, and Secretary for several public companies across a broad range of sectors.

Mr. Cherry, a Chartered Accountant since February 2009, has specialized in auditing junior public companies and IPOs during his tenure at KPMG and Davidson and Co. LLP in Vancouver. To accommodate the appointment of Christopher P. Cherry as CFO, Shawn Balaghi has resigned as Interim CFO.

However, Mr. Balaghi will continue to serve as a member of the board of directors and as the Interim CEO of the Company.